Analyst Price Target is $313.00
▼ -8.92% Downside Potential
This price target is based on 5 analysts offering 12 month price targets for West Pharmaceutical Services in the last 3 months. The average price target is $313.00, with a high forecast of $400.00 and a low forecast of $250.00. The average price target represents a -8.92% upside from the last price of $343.67.
Current Consensus is
The current consensus among 5 investment analysts is to hold stock in West Pharmaceutical Services. This rating has held steady since December 2022, when it changed from a Buy consensus rating.
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.